Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Roswell Biotechnologies Inc. is managing 2 pending office actions within the Chemistry & Materials technology area. These matters are spread across 2 distinct examiners and the specified art units, indicating a diversified prosecution landscape. This distribution suggests that the company is pursuing multiple technical paths simultaneously. The presence of different art units indicates that the portfolio covers a range of chemical innovations. With multiple units involved, the applicant must stay informed about the examination practices within the Chemistry & Materials sector.
BOWMAN, ANDREW J is the busiest examiner for the portfolio, currently handling 1 pending office action. This means that the workload is split, with the busiest examiner managing 1 of the active matters. For the practitioner, this requires coordinating responses across different art units. The involvement of multiple examiners may require a broad understanding of different examination styles. Managing the pending office actions across separate examiners ensures that the progress of one application does not directly impact the timeline of the other. Because BOWMAN, ANDREW J holds a pending action, the applicant can address this matter independently.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LU, FRANK WEI MIN | 1 | 62.7% | +67.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17839177 | PROCESSIVE ENZYME MOLECULAR ELECTRONIC SENSORS FOR DNA DATA STORAGE | LU, FRANK WEI MIN | 27d |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17839177 | PROCESSIVE ENZYME MOLECULAR ELECTRONIC SENSORS FOR DNA DATA STORAGE | LU, FRANK WEI MIN | 1683 | §112 | Final Rejection | 27d | Pending | Jun 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial